利福昔明
医学
肠道菌群
药品
肠易激综合征
抗生素
重症监护医学
生物信息学
药理学
内科学
微生物学
免疫学
生物
标识
DOI:10.1517/14656566.2011.546347
摘要
Rifaximin inhibits a broad spectrum of bacteria in the bile-rich small bowel and susceptible bacteria in the aqueous colon, and alters microbial virulence and epithelial cell function. The different mechanisms of action of rifaximin potentially explain the use of the drug in widely varied diseases and syndromes.
科研通智能强力驱动
Strongly Powered by AbleSci AI